Redwood Wealth Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Redwood Wealth Management Group, LLC
- $133 Billion
- Q2 2024
A detailed history of Redwood Wealth Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Redwood Wealth Management Group, LLC holds 33 shares of CLDX stock, worth $1,381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33Holding current value
$1,381% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.4MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$338 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$196 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$156 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$142 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$139 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.96B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...